As General Partner at Lux Capital, Deena Shakir invests across AI, healthcare and critical infrastructure. Her portfolio includes Maven, Alife, Waymark and Trial Library. These companies address some of the healthcare system’s hardest problems, from fertility and high-risk pregnancies to clinical trials.
Shakir’s early investment in Maven proved particularly consequential. Women’s health had long attracted little serious venture capital. Maven became the first unicorn focused on women’s and family health, helping establish a category that investors had largely ignored.
She now sees a similar opportunity in AI. Deena Shakir is less interested in technology for its own sake than in where it can remove genuine bottlenecks. That has led her towards healthcare, where vast amounts of knowledge, data and scientific progress often struggle to translate into better outcomes.
Her recent work has widened that focus. In 2026, she led Lux Capital’s investment in 1001 AI, a company building sovereign AI systems for critical infrastructure across the GCC. The move reflects a broader interest in technologies that must operate within complex, highly regulated systems.
Deena Shakir started her career as a journalist, reporting in Arabic and English and interning with the BBC. A speech by Barack Obama in Cairo put her on a different career path. Rather than report on the changing relationship between the US and the Middle East, she decided she wanted to play a part in it. Shakir joined the Obama administration and helped launch the first Global Entrepreneurship Summit.
She later moved to Google, initially working on social impact before joining teams developing early-stage products across healthcare, AI and search. Google gave Shakir a close view of how technology gets built. But venture capital showed her how small, poorly resourced companies could sometimes move faster and have greater impact than projects inside the world’s largest technology companies.
That realisation drew her first to GV and later to Lux Capital.
For audiences navigating AI, healthcare and technological change, Deena Shakir’s perspectives are particularly useful. She has worked on policy, built products inside Big Tech and backed companies trying to challenge the systems those institutions operate within.
